NEW ORLEANS, La.--(BUSINESS WIRE)--Ra Medical Systems, makers of cardiovascular and dermatology catheters and excimer lasers, today announced the commercial launch in the United States of the Company’s groundbreaking DABRA™ System for the treatment of Peripheral Artery Disease.

A new study by the National Institutes of Health will explore the ways in which patients with HIV can avoid heart attacks, because one could be especially deadly for someone with the condition, reports the Baltimore Sun.

New research from Boston University shows that many of the artery problems people experience as they age could be avoided or delayed.

In an effort to battle Peripheral Artery Disease (PAD), the leading cause of limb amputations, the Food and Drug Administration (FDA) announced today that it has granted market clearance to Ra Medical Systems, makers of excimer lasers and catheters for cardiovascular and dermatological diseases, for the Company’s groundbreaking DABRA System.

A new study led by scientists at Oxford University have found the link between strep throat and rheumatic heart disease could be dependent on a patient’s genetic makeup, not just how quickly they receive antibiotics, reports the New York Times.

Methamphetamine abuse significantly increases one’s morbidity leading to complications such as arrhythmias, hypertension and methamphetamine-associated cardiomyopathy (MACM).

Medicare now covers a supervised exercise therapy for peripheral artery disease (PAD), according to CMS, a decision that will likely result in other insurers following this example.

Scientists from China have developed a new paper strip test that could allow heart failure patients to monitor their condition at home.